Dogwood Therapeutics, Inc.
DWTX
DELAYED 1 MONTH

4 insider filings · Latest: Mar 5, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 5, 2026Mar 6 9:20 PMRalph GrosswaldSVP OF OPERATIONS
Grant/Award
82,500$2.8682,500(D)

View →

Mar 5, 2026Mar 6 9:18 PMAngela WalshChief Financial Officer
Grant/Award
82,500$2.8682,500(D)

View →

Mar 5, 2026Mar 6 9:17 PMRoger Michael GendreauCHIEF MEDICAL OFFICER
Grant/Award
82,500$2.8682,500(D)

View →

Mar 5, 2026Mar 6 9:16 PMDuncan Gregory ScottDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
330,000$2.86330,000(D)

View →